Type1Screen

Did you know? Clinical trials across Australia are testing new therapies that may help protect the insulin-producing beta cells targeted in type 1 diabetes.
Preserving even a small number of beta cells could make type 1 diabetes easier to manage, reduce hypos, and improve quality of life.
Trials are available for people newly diagnosed with type 1 diabetes and those identified through screening as being at risk.
For more information on these clinical trials, visit ATIC or their website https://atic.svi.edu.au
For more information on screening visit our website: https://type1screen.org

DKA is a a serious condition that happens when there is not enough insulin in the body. In many cases of new type 1 diabetes, the body has already lost most of its insulin-producing ability before anyone realises something is wrong. So, often people are in DKA before they know that they have type 1 diabetes.

Avoiding DKA at diagnosis is important because DKA is dangerous and requires emergency treatment in hospital. It is also physically and emotionally traumatic.

Knowing your risk allows type 1 diabetes to be diagnosed before the emergency of DKA happens so that:
• Emergency medical treatment is not required
• Insulin treatment can start calmly and safely
• People can explore their options for therapies or clinical trials of therapies to delay the onset of type 1 diabetes.

For more information on screening visit our website: https://type1screen.org

UPDATE!
We are now able to offer the MT-101-101 study in Queensland and Victoria. If you are an adult with type 1 diabetes and are interested in taking part in research for a new treatment, please contact us via the details in the image or visit our website atic.svi.edu.au/clinical-trials

UPDATE:
The SAFEGUARD study is now available in more locations around Australia and New Zealand!
If you have been diagnosed with type 1 diabetes in the last 100 days and are interested in being involved in a clinical trial of a new medicine that is hoped to protect the body's ability to make insulin, please reach out via the details in the image or visit our website at atic.svi.edu.au/clinical-trials/

On Sunday, Professor John Wentworth spoke with Dr Ross Walker on the Healthy Living program across 2GB, 3AW, 4BC and 6PR radio stations. They discussed the recent approval of TZield and the importance of screening for type 1 diabetes. You can find out more about screening for type 1 diabetes on our Type1Screen website and you can visit ATIC for information about the clinical trials that John and Ross speak about.

Potential delay of the onset of clinical Type 1 diabetes - Healthy Living Dr Ross Walker speaks with Professor John Wentworth, Endocrinologist and Senior Clinical Research Fellow at St Vincent's Institute of Medical Research. We discuss the TGA’s historic registration of Tzield, the very first non-insulin medicine designed to delay the onset of clinical Type 1 diabetes....

The Type1Screen team had a great day at The Type1 Foundation Family Fun Day at SeaWorld last weekend. It was a pleasure to meet so many wonderful families and to share information about screening for type 1 diabetes. Thank-you to Ange and the team at The Type 1 Foundation for having us along to take part in this wonderful day. If you would like more information about screening for type 1 diabetes, please visit our website https://type1screen.org

Following the approval of Tzield in Australia last week, we received a lot of questions about the stages of T1D. Our friends at Breakthrough T1D Australia have produced this wonderful image that explains the stages in detail. They also have more information available on their website at https://breakthrought1d.org.au/early-detection-of.../stages/

Do you like podcasts??
Prof John Wentworth was interviewed by Stu from Lost in Science recently. They discussed all things type 1 diabetes and screening. This is a great interview to share with friends and family who might need some more information about screening for type 1 diabetes. Happy listening!

Type1Screen with Dr. John Wentworth Stu catches up with Dr. John Wentworth from the Royal Melbourne Hospital to talk about Type1Screen, a nationwide project aiming to identify people at risk of developing Type 1 diabetes in order to develop treatments to prevent progression of the illness. See https://type1screen.org/ for more details

There was a wonderful buzz in the type 1 diabetes world last week when Tzield was the first immunotherapy approved for use in Australia for people with stage two, type 1 diabetes.
But was is an immunotherapy? And how does it work in type 1 diabetes?
Our friends at ATIC shared this fantastic explainer video last week to answer these questions!

New ATIC Video Resource | ATIC The ATIC Community Engagement Panel has led the development of a new video resource designed to raise awareness among health professionals and the community about the benefits of immunotherapy for type 1 diabetes.